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ABSTRACT 12 
The genotyping of a single-nucleotide polymorphism (SNP) is addressed through methods 13 
based on loop-mediated isothermal amplification (LAMP) combined with user-friendly optical 14 
read-outs to cover the current demand for point-of-care DNA biomarker detection. The 15 
modification of primer design and reaction composition improved the assay selectivity yielding 16 
allele-specific results and reducing false-positive frequency. Furthermore, the reduced cost, 17 
ease of use and effectiveness of colorimetric detection (solution and hybridization chip 18 
formats) were availed for the image capture by a smartphone, reching high sensitivity. In order 19 
to evaluate their discriminating capacities, LAMP-based methods were applied to human 20 
samples to genotype an SNP biomarker (rs1954787) located in the GRIK4 gene and related to 21 
the treatment response to anti-depressants drugs. Sensitive (limit of detection: 100 genomic 22 
DNA copies), reproducible (<15% error), fast (around 70 min) and low-cost assays were 23 
accomplished. Patient subgroups were correctly discriminated, agreeing with reference 24 
sequencing techniques. The achieved analytical performances using the developed 25 
amplification-detection principles confirmed the approach potential for point-of-care optical 26 
DNA testing.  27 
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1. Introduction 32 
Rapid advances made in DNA biomarkers research are providing us with a better 33 
understanding of disease mechanisms and drug action, which can lead to offering new 34 
personalised medicine opportunities (Wooley et al., 2014). The key step for implementing such 35 
systems in clinical routine is to employ highly efficient testing methods, which have to be 36 
accurate and sensitive enough to detect even minority variants, but also practical and 37 
economically feasible. In recent years, several studies have examined the capabilities of point-38 
of-care (POC) genetic testing (Dobson et al., 2007). These tests generally include a cost-39 
effective field-portable device, along with an accurate, sensitive and simple DNA assay. 40 
Amplification reactions are central to DNA-based diagnostic methods because sensitivity 41 
and selectivity depend on the effective increment in the copy number for the target region 42 
(Vashist et al., 2015). The most widely used amplification method is polymerase chain reaction 43 
(PCR), but it has some limitations for POC applications: a specific instrument for strict 44 
temperature control, susceptibility to amplification yield variations related to reaction 45 
conditions or the formation of air bubbles in miniaturised devices (Deng et al., 2015). Scientific 46 
advances have led to several enzymatic reactions run at constant temperature that can be used 47 
as an alternative to PCR-based amplification. Some recent reviews summarise isothermal 48 
amplification reactions and their use as analytical tools (Craw et al., 2012; Yan et al., 2014; Li 49 
2015).  50 
Loop-mediated isothermal amplification (LAMP), developed by Notomi et al. 2000, is the 51 
most extensively studied isothermal amplification technique. The main advantages over other 52 
approaches are its high amplification yield, good tolerance to inhibitors, short time and 53 
compatibility with several detection principles. The conventional approach relies on four 54 
primers to recognise six different sequences of the target DNA, which also leads to very high 55 
specificity. The action of a highly strand-displacing DNA polymerase (Bst polymerase) 56 
generates large amounts of dumbbell-like structures under isothermal conditions (60–65°C). In 57 
virtue of these features, LAMP-based methods have been extensively applied to diagnose 58 
infectious diseases by detecting bacteria, viruses and parasites (Parida et al., 2008; Connelly et 59 
al., 2015).  60 
In the last few years, several studies have demonstrated LAMP’s capability to discriminate 61 
single-base variations, such as single nucleotide polymorphisms (SNPs) and somatic point 62 
detection. These methods are based on allele-specific hybridisation (Jiang et al., 2015, 63 
Nakamura et al., 2007), and amplification using allele-specific primers (Zhang et al., 2014; 64 
Yongkiettrakul et al., 2017) or a blocking agent (Itonaga et al., 2016). However, these methods 65 
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usually rely on naked-eye visualisation or carry out the detection with expensive and bulky 66 
laboratory equipment (e.g. electrochemical stations, real-time turbidimeter or fluorometer). 67 
With the adequate integration to user-friendly detection technologies, these LAMP variants are 68 
appealing to develop POC testing. Examples of candidate clinical challenges are to select the 69 
correct oncological treatment with monoclonal antibodies (Shackelford et al., 2012), and to 70 
adjust drug doses in neuropathies and psychiatric disorders (Chan et al., 2011, Hamilton, 2015).  71 
We herein explored these discrimination principles to develop high-performance POC 72 
systems. The first method involved the allele-specific oligonucleotide hybridisation of the 73 
LAMP products in the stem-loop region (LAMP-ASO). The second was based on the annealing 74 
selectivity of allele-specific inner primers (3’AS-LAMP), while discrimination in the third 75 
approach relied on DNA synthesis from a dumbbell-like starting structure (5’ AS-LAMP). The 76 
key conditions to obtain adequate amplification yield, improve the discrimination factor and 77 
reduce false-positive frequency, were investigated. To this end, modifications in the 78 
primer/probe design, and variations in the amplification or hybridisation mix composition, 79 
were included. 80 
Detection of allele specific products in POC scenarios also requires alternative detectors to 81 
previous LAMP approaches. In line with this, the features of consumer electronic devices are 82 
excellent as they are ubiquitous, low-cost, compact and high-performance products that can 83 
benefit advanced analytical measurements (Kido et al., 2000; Maquieira, 2012; Ozcan, 2014; 84 
Quesada-González et al., 2016). The sensing devices described for diagnostic purposes include 85 
compact disc drivers (Morais et al., 2014), flatbed scanners (Tortajada-Genaro et al., 2016) and 86 
mobile phones (Roda et al., 2016; Kanchi et al., 2018), among others. In this study, we explored 87 
the colorimetric detection of the developed homogeneous and heterogeneous LAMP assays 88 
supported by smartphone technology due to its widespread presence, portability and capacity 89 
to transmit data at a user-friendly interface. This integrated system also fulfils WHO 90 
requirements, and corresponds to the acronym “ASSURED”: affordable, sensitive, specific, 91 
user-friendly, rapid and robust, equipment-free, and delivered to those who need it. 92 
 93 
2. Material and Methods 94 
2.1. Primers and probes 95 
LAMP primers and probes were designed for the target SNP according to the 96 
thermodynamic parameters described in the literature (Notomi et al., 2000, Tortajada-Genaro 97 
et al., 2017). The complete design strategy and oligonucleotide sequences can be found in the 98 
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Supplementary Material. All the oligonucleotides used in this study were purchased from 99 
Eurofins (Luxembourg).  100 
2.2. LAMP combined with allele-selective oligonucleotide hybridisation: LAMP-ASO 101 
method 102 
In this approach, isothermal amplification was followed by hybridisation to the specific 103 
probes immobilised on planar polycarbonate chips (25 × 75 mm). Non-allele selective LAMP 104 
amplification was carried out in 200 µL propylene phials with primers that enclosed the 105 
polymorphic site. Each reaction (12.5 µL) was composed of 1× isothermal amplification buffer 106 
(20 mM Tris-HCl, 10 mM (NH4)2SO4, 50 mM KCl, 2 mM MgSO4, 0.1% Tween 20, pH 8.8), 107 
1.5 M betaine, further 6 mM MgSO4, 1.2 mM dNTPs, 10 µM digoxigenin-11-deoxyuridine 108 
triphosphate (DIG-dUTP), 0.2 µM of outer primers, 1.2 µM of inner primers, 0.32 U/µL Bst 109 
polymerase 2.0 (New England Biolabs, USA) and 0.32 ng/µL (approximately 100 copies per 110 
µL) of the studied DNA. Vials were incubated at 62°C for 60 min (digital heat block, VWR). 111 
Amplification products were then hybridised with the allele-specific oligonucleotide probes 112 
immobilised on chips in a microarray format. Probe arraying, hybridisation and colorimetric 113 
staining were performed according to the protocol developed in previous works (Tortajada-114 
Genaro et al., 2016, Yamanaka et al., 2017). The resulting hybridisation products anchored to 115 
the surface were recognised by horseradish peroxidase-conjugated antibodies and stained by 116 
3,3’,5,5’-tetramethylbenzidine to produce a precipitate. 117 
A digital imaging technique was used to record the LAMP-ASO results. Array images 118 
were captured by a smartphone (MotoG first generation, Motorola) using a homemade capture 119 
chamber (8.0 x 6.7 x 4.4 cm). This chamber had a frontal rectangular aperture for the 120 
smartphone camera, a lateral hole to illuminate the array by an external optical fibre light source 121 
(20W power, 3,000 K colour temperature, LE.5209 model, Euromex, Holland), and an inferior 122 
aperture to insert the assay chip. The image was captured after adjusting both focus and 123 
exposure (75% saturation) and was converted into a tagged image file format on a 16-bit (0-124 
65,535) greyscale with the ImageJ software (National Institutes of Health, USA). Images were 125 
analysed and the resulting spot intensities were expressed in signal-to-noise ratio terms. 126 
 127 
2.3. Allele-specific LAMP: 3’AS-LAMP and 5’ AS-LAMP formats 128 
Two homogeneous amplification formats were assayed using allele-specific primers (see 129 
Supplementary Material). In each case, discrimination was achieved using two reaction 130 
mixtures to amplify the wild-type variant (wild-type primers) or the mutant variant (mutant 131 
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primers). For 3’ AS-LAMP format, the polymorphism was located at the 3’-end of the forward 132 
inner primer (FIP), leading two allele-specific primers and a reverse inner primer common to 133 
both reaction mixtures. Therefore, the reaction mixture composition varied from the previously 134 
described non-selective LAMP by using each FIP primer, 1.25 M betaine and 300 µM 135 
hydroxynaphtol blue. In the 5’ AS-LAMP format, the polymorphism was located at the 5’-end 136 
of both FIP and BIP, and the difference in mixture composition was the betaine and dyer 137 
concentrations, which were 0.75 M and 300 µM, respectively. On-chip amplification was 138 
carried out with a rhombic chamber chip (reaction volume 10 µL, Zeonor material) supplied 139 
by microfluidic ChipShop (Germany). Inlets and outlets were connected directly to Tygon 140 
tubing. Chips were loaded with the amplification samples and were incubated at 62°C for 60 141 
min. 142 
Smartphone imaging enabled end-point direct colorimetric detection. For this purpose, 143 
the reaction chip with a reference colour palette was placed in the previously described 144 
detection assembly. The AssayColor software (Alidans, Italy), installed in the smartphone, was 145 
used to capture and analyse images. This scientific application, developed for the Android 146 
operating system, provided colour intensities in the red, green and blue channels (RGB) for 147 
each LAMP product. The R/G intensity ratio was selected as an analytical signal.  148 
 149 
2.4. Sample analysis 150 
Subjects (n=15) were recruited according to ethics with informed consents. DNA extracts 151 
were obtained from the buccal smear samples with the Purelink Genomic DNA mini kit 152 
(Thermo Fisher Scientific, USA). Purified products were eluted with Tris-HCl buffer (Tris 10 153 
mM, pH 8.6) and their genomic DNA content was quantified in a NanoDrop 2000 154 
spectrophotometer (Thermo Fisher Scientific, USA). A 260/280 nm absorbance ratio above 1.8 155 
was considered to determine adequate purity. Extracts were diluted to 4 ng/µL and stored at -156 
20°C until further use. Subsequently, samples were submitted to the LAMP-ASO, 3’AS-LAMP 157 
and 5’AS-LAMP methods. A no-template control and a Salmonella typhimurium DNA extract 158 
were used to check for false-positive assays. A discrimination index was calculated from the 159 
signal of the wild-type (WT) and mutant (MUT) responses according to the following equation: 160 
(WT − MUT)/(WT + MUT). The genotype was assigned according to discrimination 161 




2.5. Genotyping validation 164 
Two techniques were used to confirm patients’ genotypes: Sanger sequencing and allele-165 
specific PCR.  166 
For Sanger sequencing, each PCR reaction was carried out in a mixture (12.5 µL) that 167 
contained 1x amplification buffer, 3 mM MgCl2, 200 µM dNTPs, 300 nM of the forward and 168 
reverse primers, 0.5 units of Taq polymerase (Biotools, Spain) and 20 ng of genomic DNA per 169 
reaction. Amplification was carried out in a UnoCycler thermal cycler (VWR, USA) according 170 
to the following programme: initial denaturation at 95°C for 5 min, followed by 35 171 
amplification cycles of denaturation (95°C for 30 s), annealing (60°C for 30 s) and elongation 172 
(72°C for 30 s), and a final extension step at 72°C for 5 min. The resulting amplification 173 
products were diluted, extended with fluorescent dideoxynucleotides (Big Dye Terminator 174 
Cycle Sequencing Kit v3.1, Thermo Fisher Scientific, USA), and analysed in a fluorescence-175 
capillary sequencer (ABI 3130xl Genetic Analyzer, Applied Biosystems, USA). 176 
Allele-specific PCR (AS-PCR) was based on the use of two forward primers that differed 177 
at the 3’-end nucleotide, and were complementary to the wild-type or mutant variant. An 178 
additional mismatch at the penultimate nucleotide was included. The amplification conditions 179 
were identical to those previously described for PCR, except for the use of the allele-specific 180 
primers and an annealing temperature of 62°C. End-point fluorescence was measured to 181 
confirm amplification. Products were diluted in 0.5× SYBR Safe (Invitrogen, USA) on a 96-182 
well black polystyrene plate and analysed in a plate reader (Victor 3TM V1420, Perking Elmer, 183 
Finland) at excitation and emission wavelengths of 485 and 535 nm, respectively. 184 
 185 
The Statgraphics Centurion statistical package for Windows v.16 was used for the data 186 
analysis.  187 
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3. Results and Discussion 188 
3.1. ASO-LAMP set-up 189 
SNP discrimination was performed with the combination of isothermal DNA 190 
amplification and hybridisation with allele-selective probes in a solid-phase format.  191 
The first step was the oligonucleotide design (primers and probes). There were two 192 
design options according to the target polymorphism location in the LAMP product loop-193 
structure: central position (double-strand region) or loops (single-strand regions). The second 194 
option was chosen to improve the hybridisation yield to the array probe (Fig. 1a). A 195 
thermodynamic analysis was used to select the candidate probes that maximised the 196 
hybridisation of perfect-match pairs (wild-type or mutant) and hampered the coupling of 197 
mismatched products (wild-type product/mutant probe or mutant product/wild-type probe). An 198 
additional design restriction was the central position of the polymorphic mismatch in the probe 199 
to increase assay selectivity. The selected sequences produced wide variation in standard free 200 
energies, expressed as the difference between the single-base mismatch (∆Gºmutant) and the 201 
perfect match (∆Gºwild-type). Estimated values were 3.3-4.5 kcal/mol. 202 
The LAMP reaction was optimised to selectively amplify the targeted region using the 203 
designed non-allele-specific primers. Reagent concentrations (enzyme, inner primers and outer 204 
primers), amplification temperature and reaction time were studied by the fluorescence analysis 205 
(see the Supplementary Material). Negative controls (non-human DNA) produced a signal 206 
comparable to the background, while the amplification of the human DNA template generated 207 
a significantly distinguishable signal (Fig. 1b). The wild-type and mutant templates produced 208 
similar amplification curves, and the time selected for the end-point analysis was 60 min. The 209 
amplification factor was (2.6±0.8)×108, which gave a 23-fold higher yield than a typical PCR 210 
using the same external primers and the amount of the initial DNA template.  211 
The next experiments focused on the selective hybridisation to the probes anchored to 212 
the plastic chip, by directly dispensing the end-point LAMP product on the probe arrays. This 213 
approach is simpler and more efficient than combining PCR-based methods with microarray 214 
detection because an intermediate (thermal or chemical) denaturalisation step is generally 215 
required (Wooley et al., 2014, Tortajada-Genaro et al., 2016). The probe immobilisation 216 
parameters (concentration, drop volume, and surface treatment) and the hybridisation variables 217 
(buffer composition, time and washing cycle) were studied to balance yield and selectivity, as 218 
described in the Supplementary Material. The most critical variable to achieve selective 219 
hybridisation was buffer composition, particularly formamide concentration (Figure 1c). Under 220 
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the optimal conditions (1x sodium saline citrate buffer, 30% formamide), a detectable signal 221 
was obtained for the perfect-matched duplexes (wild-type and mutant homoduplex), while a 222 
background-equivalent response was acquired for the mismatch hybrids. 223 
 224 
3.2. AS-LAMP set-up 225 
In the preliminary studies, a non-specific amplification signal was generated for the non-226 
matched primer-template pairs. The LAMP assays generated false-positives due to the 227 
formation of unexpected primer structures, as observed in other studies (Connelly et al., 2015; 228 
Wang et al., 2015). Therefore, several modifications were made to increase assay selectivity in 229 
the AS-LAMP formats. Firstly, an additional mismatch was deliberately added to the 230 
penultimate nucleotide of the allele-specific primers. Major destabilisation of the hybridization 231 
process was estimated for the mismatch probes, where the calculated variation of the standard 232 
free energies was about 1.2 - 2.8 kcal/mol. Secondly, the effect adding betaine to the 233 
amplification mix was evaluated. This amino acid analogue is often used for destabilising 234 
dsDNA and for reducing the sequence composition influence on the melting temperature. The 235 
experiments showed that adding betaine eliminated the false-positive results associated with 236 
the mismatch hybrids (Fig. 2). However, increasing the betaine concentrations also led to the 237 
undesired inhibition of the perfect-matched duplexes. The inhibition effect was more 238 
prominent in the 5’ allele-specific format than in the 3’ one. This could be explained by the 239 
lesser stability of the associated perfect-match hybrids (about 5 kcal/mol) and a different 240 
number of allele-specific primers (two in the 5’ format and one in the 3’ format). In summary, 241 
the results at the selected values (1.25 M for 3’AS-LAMP and 0.75 M for 5’AS-LAMP) showed 242 
better amplification selectivity compared to conventional conditions.  243 
Amplification kinetics was studied to verify the discrimination capacity and the assay 244 
turnout time for the LAMP reactions. Both the allele-specific methods showed adequate 245 
selectivity as the real-time signals for the no-template control and the non-human DNA extract 246 
(Salmonella culture) were similar to the background. When the perfectly matched primers were 247 
used, amplification started at 40 min for the 3’ and 5’ allele-specific approaches, while the 248 
mismatched primers generated a signal after a delay that went beyond 30 min in both cases. It 249 
is worth noting that the stability difference between the previously described matched and 250 
mismatched duplexes was also reflected in the amplification kinetic profiles. Longer delays for 251 
the mismatched pairs were found in the 3’ format. After considering the results, a 60-minute 252 
amplification time was selected for the following experiments to prevent the formation of non-253 




3.3. Smartphone detection 256 
The detection of the previously described allele-selective products was achieved with 257 
conventional laboratory instruments; i.e. fluorescence qPCR thermocycler, fluorescence 258 
spectrophotometer or fluorescence scanner. The next challenge was to adapt the methods for 259 
colorimetric detection using a smartphone (complementary metal–oxide–semiconductor, 260 
CMOS sensor) suitable for point-of-care testing. An integrated detection device was assembled 261 
for chip reading, which comprised a light source, a dark chamber and the smartphone aligned 262 
to the chip (Fig. 3). To guarantee inter-assay measurement robustness, a colour pattern (a violet 263 
to blue scale) was photographed together with the assay platforms. The specific measuring 264 
conditions were optimised to digitalise the array profile by the smartphone camera, as the 265 
Supplementary Material describes. Image resolution, expressed as pixel width, was 17 µm. 266 
For the LAMP-ASO approach, a colorimetric detection method for the probe-LAMP 267 
product hybrids based on an immunorecognition step (digoxigenin/primary 268 
antibody/secondary antibody system) and enzymatic staining (horseradish 269 
peroxidase/colorimetric substrate system) was studied. If hybridisation was positive, a blue 270 
precipitate was generated on the spot by attenuating the captured optical density (reflection-271 
mode detection). The intensity of each array spot (400 µm diameter) was calculated as the 272 
average of 448 pixels. A perfect-match interaction (LAMP product/probe) produced signals up 273 
to 56,000 a.u. in 16-bit greyscale units, while the chip background values were in the range of 274 
7,000±400 a.u.. Therefore, the spot intensities discriminated positive and negative recognition 275 
events depending on the probe/product pair. Statistical significance was calculated by a 276 
Student’s t-test, and p-values were <0.05 in all cases. This study demonstrates, for the first 277 
time, the colorimetric detection of allele-specific hybridisation LAMP products, which 278 
produces excellent versatility and is a key factor to make a simpler reader-suitable method for 279 
POC applications. 280 
For the AS-LAMP approaches, the addition of a magnesium indicator (hydroxynaphtol 281 
blue) was evaluated (Zhang et al., 2014b). Along with the capacity of the isothermally 282 
amplifying double strand DNA, a very high yield is an interesting advantage that LAMP offers 283 
over conventional PCR and other isothermal amplification methods, as it allows a subsequent 284 
direct colorimetric detection with a smartphone. This staining method was simple and did not 285 
require any additional devices (i.e. ultraviolet source, wavelength filters, magnification lens). 286 
Detection was achieved with no post-amplification steps. To improve the recorded responses 287 
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(scattered light), the concentration of hydroxynaphtol blue was gradually increased and the 288 
light intensity for the RGB channels was recorded (Fig. 3). Concentrations above 300 µM 289 
provided a significant signal of red channel for the positive amplifications compared to the 290 
negative controls (test t: t=2.25, p<0.05). From the obtained results, the proposed modification 291 
of ASA-LAMP approaches showed excellent signal discrimination, which indicates its 292 
potential as a polymorphism biomarker analysis tool. 293 
 294 
2.4. Comparing methods 295 
The main features and analytical performances of the three methods were subsequently 296 
compared (Table 1). Analytical sensitivity and reproducibility were calculated from the 297 
consecutive dilutions of a genomic human DNA template. Although naked-eye colour 298 
observation was possible to visualise positive amplification (violet to sky blue), the use of an 299 
imaging/sensing device guaranteed reliable measurements when smaller amounts of the target 300 
SNP were present in the sample and colour change was subtle. The estimated limit of detection 301 
was 100 copies for the all LAMP-smartphones-based methods. Thus the required amount of 302 
genomic DNA was smaller than previous LAMP approaches (Nakamura et al., 2007, Itonaga 303 
et al., 2016), some genotyping assays (Gibriel et al., 2017) and sequencing techniques 304 
(Goodwin et al., 2016). Assay repeatability, calculated from replicates, yielded error rates 305 
under 15% in all the formats, which were lower than those obtained by naked eye visualisation 306 
and similar to other SNP methods that have been applied to human samples.  307 
The technical requirements for developing point-of-care systems were also evaluated. 308 
The estimated reagent cost of LAMP-ASO was 2.65-fold higher than the AS variants, mainly 309 
because of immunoreagent prices. Compared with the corresponding PCR approaches, LAMP 310 
assays were more expensive (about 1.5-fold), mainly due to the cost of enzymes (Bst 311 
polymerase versus Taq polymerase). In contrast, the LAMP approaches only required a low-312 
cost heating system (62°C; i.e. heater) compared to the conventional thermal cycler used in 313 
PCR-based methods, along with a cheaper and more practical detector. The LAMP methods 314 
also worked in shorter analysis times than their equivalent PCR approaches. The AS-LAMP 315 
formats were the quickest (70 min) compared to LAMP-ASO (140 min), AS-PCR (120 min) 316 
or PCR-ASO (190 min), mostly because of the shorter amplification times in the LAMP-based 317 
methods. Hence these results are similar, or better, than those obtained for previous LAMP 318 




2.5. Patient sample analysis 321 
Psychiatric pharmacogenetics is a candidate field for developed POC genotyping 322 
methods (Milanesi et al., 2015). As proof of concept, the genotyping of the rs1954787 323 
polymorphism, located in the GRIK4 gene, was selected to determine the genetic predisposition 324 
of antidepressant treatment from the human DNA (n=15) extracted from buccal swabs. Only 325 
by following the developed methodology were signals sufficiently different to achieve a 326 
specific response profile depending on the genetic variant. Figure 4 shows the subsequent 327 
discrimination graph. The three methods provided the same genotypes for all patients, except 328 
for patient 8 in the LAMP-ASO approach. Nevertheless, the homogeneous approaches (3’ AS-329 
LAMP and 5’ AS-LAMP methods) provided clearer discrimination factors than the solid 330 
hybridisation format (LAMP-ASO) due to their lower signals for the mismatched reaction 331 
mixtures. Among the analysed samples, six patients (40%) were identified as being mutant 332 
homozygous (CC) which can be related to a better chance of positive responses to depression 333 
treatment (Horstmann, 2010). There were also six heterozygous patients (40%), who were 334 
expected to give a normal response for drugs like citalopram. Finally, the results indicated that 335 
three (20%) subjects presented a homozygous wild-type genotype (TT), which indicates a 336 
higher risk of a non-response. Another comparison of the reference results (Sanger sequencing 337 
and AS-PCR) revealed a perfect correlation with the genotypes determined by the LAMP-338 
based assays.  339 
The clinical implications of this in vitro diagnostic assay were analysed. Major 340 
depressive disorder affects were about 10-15% of the population (annually), with a degree of 341 
uncertainty about the individual efficacy of the antidepressant treatment (Kawaguchi et al., 342 
2014). The discrimination of specific polymorphisms can enable quick personalised patient 343 
management with a strong effect on therapy. Clinical trials have identified an association of 344 
rs1954787 with therapy effectiveness, and have reported that CC homozygotes are more likely 345 
to respond to treatment than TT homozygotes. Therefore, a simple low-cost genotyping tool 346 
can support the better dosing of antidepressants. 347 
 348 
4. Conclusion 349 
This research confirms the excellent features of LAMP as a viable alternative to current 350 
methodologies whose aim is genotyping purposes in order to overcome the associated technical 351 
barriers. This study particularly supports the oligonucleotide design and the selection of 352 
reaction conditions for colorimetric detection in both homogeneous and heterogeneous 353 
formats. An accurate control of these experimental variables is required because false-positive 354 
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results are more frequent than for PCR-based methods. Our results endorse the technical 355 
capabilities of smartphones as analytical readers for molecular diagnostic systems. Despite 356 
having a worse optical resolution than benchtop instruments, CMOS sensor chips incorporated 357 
into phone cameras offer adequate imaging features and widespread availability, which make 358 
them ideal detectors for cost-effective assays. Compared to other electronic devices, 359 
smartphone technology has additional advantages, such as assay reader, given its capability to 360 
transmit data, ubiquity and users’ familiarity to handle it. 361 
The achieved LAMP discrimination process and low-cost detector combination shows 362 
excellent performance and a wide dynamic range, which allows the technique to be 363 
extrapolated other target genetic biomarkers. This offers researchers the chance to develop 364 
integrated systems, which enable quicker monitoring of genetic predispositions to develop 365 
certain diseases or to predict genomic-related responses to drug therapies.  366 
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